Human kallikrein 10, or the normal epithelial cell specific-1 (NES1), a serine protease, is down-regulated in breast and prostate cancer cell lines, and functions as a tumour suppressor (Goyal et al, 1998). This evidence concerns the gene KLK10 and prostate carcinoma.